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Donors and other development partners commonly introduce innovative practices and technologies to
improve health in low and middle income countries. Yet many innovations that are effective in
improving health and survival are slow to be translated into policy and implemented at scale. Under-
standing the factors inﬂuencing scale-up is important. We conducted a qualitative study involving 150
semi-structured interviews with government, development partners, civil society organisations and
externally funded implementers, professional associations and academic institutions in 2012/13 to
explore scale-up of innovative interventions targeting mothers and newborns in Ethiopia, the Indian
state of Uttar Pradesh and the six states of northeast Nigeria, which are settings with high burdens of
maternal and neonatal mortality. Interviews were analysed using a common analytic framework
developed for cross-country comparison and themes were coded using Nvivo. We found that programme
implementers across the three settings require multiple steps to catalyse scale-up. Advocating for gov-
ernment to adopt and ﬁnance health innovations requires: designing scalable innovations; embedding
scale-up in programme design and allocating time and resources; building implementer capacity to
catalyse scale-up; adopting effective approaches to advocacy; presenting strong evidence to support
government decision making; involving government in programme design; invoking policy champions
and networks; strengthening harmonisation among external programmes; aligning innovations with
health systems and priorities. Other steps include: supporting government to develop policies and
programmes and strengthening health systems and staff; promoting community uptake by involving
media, community leaders, mobilisation teams and role models. We conclude that scale-up has no magic
bullet solution e implementers must embrace multiple activities, and require substantial support from
donors and governments in doing so.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).cer), dipankar.bhattacharya@
m (R. Dimka), feleft2@yahoo.
c.uk (L. Mangham-Jefferies),
), addishoneyt@yahoo.com
k (G. Walt), deepthi.
Ltd. This is an open access article u1. Introduction
There is growing attention on how to build on the achievements
of the Millennium Development Goals after 2015. In the ﬁeld of
health this means continuing to improve the effectiveness of health
policies and programmes and to extend their reach to the
maximum number of beneﬁciaries. Donors and other development
partners commonly introduce innovative practices and technolo-
gies to improve health in low and middle income countries. Yet
many effective innovations are slow to be translated into policy and
implemented at scale. Understanding the factors inﬂuencing scale-nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Box 1
Examples of innovative technologies and practices.
 Increasing capacity, broadening roles and incentivising
frontline workers including community health workers
and traditional birth attendants
 Introducing tools to enhance frontline worker perfor-
mance including communications materials, mobile
phone technologies and quality assurance measures
 Strengthening healthcare referral systems to increase
facility deliveries through introducing emergency trans-
port schemes, an MNH call centre and strengthening the
role of community health workers and traditional birth
attendants in making referrals
 Strengthening community structures to raise awareness,
promote behaviour change and make decisions locally
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et al., 2013; Gawande, 2013).
There are multiple meanings of ‘scale-up’ including increasing
ﬁnancial, human or capital programme inputs and increasing pro-
gramme reach to beneﬁt greater numbers of people over wider
geographical areas (Mangham and Hanson, 2010). We deﬁne scale-
up as: ‘… an increase in the coverage of health interventions that have
been tested in pilot and experimental projects in order to beneﬁt more
people …’ (Mangham and Hanson, 2010:2 after Simmons et al.,
2007). There is an extensive literature on the factors inﬂuencing
lack of or limited adoption and scale-up of innovations in health and
other sectors. Factors include the features of an innovation such as
its simplicity, comparative advantage and whether beneﬁts can be
observed (Fajans et al., 2006; WHO and ExpandNet, 2009, 2010,
2011; Simmons et al., 2010). The characteristics, needs and atti-
tudes of potential adopters e the ‘receiving environment’ e inﬂu-
ence their willingness or ability to accept new practices or
technologies, and ‘change agents’ such as policy champions and
community opinion leaders can inﬂuence government adoption,
and community acceptance of an innovation (Ryan and Gross,1943;
Rogers,1962; Greenhalgh et al., 2004; Fajans et al., 2006; Cooley and
Kohl, 2006; Dearing, 2008;WHO and ExpandNet, 2009, 2010, 2011;
Linn et al., 2010; Simmons et al., 2010; Yamey, 2011; Bradley et al.,
2012). The political, economic and social contexts within which
innovations are introduced are important. Decision makers' values,
ideas and ideologies often shape health priorities andwhich policies
and programmes are adopted or rejected, and decisions are inevi-
tably constrained by ﬁnancial resources and inﬂuenced by prevail-
ing social attitudes (Cooley and Kohl, 2006; Shiffman, 2010; Linn
et al., 2010; WHO and ExpandNet, 2009, 2010, 2011). Different ac-
tors have different levels of power to inﬂuence policy decisions,
including the power of civil society advocates to make demands of
governments (Sabatier and Jenkins-Smith, 1993; Walt and Gilson,
1994; Cooley and Kohl, 2006; Shiffman, 2010; Harmer et al., 2013).
There are aspects of health systems that enable or constrain the
delivery of innovations at scale including health workers' training
and attitudes, and the strength of supply chains and supervision
systems (Hanson et al., 2003; Fajans et al., 2006; Simmons et al.,
2007; Mangham and Hanson, 2010; WHO and ExpandNet, 2010;
Simmons et al., 2010). Community uptake of an innovation may
be inﬂuenced by sociocultural values and norms, health beliefs and
practices, while access may be constrained by economic,
geographical and bureaucratic barriers (Cooley and Kohl, 2006;
Fajans et al., 2006; Gilson and Schneider, 2007).
While there is a rich conceptual literature, few empirical studies
of the adoption, scale-up and diffusion of innovative practices and
technologies have focussed on low- and middle-income countries.
We conducted a qualitative study to explore scale-up of innovative
maternal and newborn health (MNH) interventions targeting
mothers and newborns within poor, vulnerable populations in
Ethiopia, the Indian state of Uttar Pradesh and the six states of
northeast Nigeria, which are settings with some of the highest
burdens of maternal and neonatal mortality in the world. Our aim
was to identify the key activities that implementers of externally
funded MNH and other health programmes can adopt to catalyse
scale-up of their innovations beyond their intervention districts.
2. Methods
Informed by the above literature our study aimed to capture the
key activities we expected externally funded implementers to
adopt in an effort to catalyse scale-up as follows:
 Designing scalable innovations;
 Planning scale-up; Persuading government to accept, adopt and ﬁnance in-
novations at scale;
 Supporting and enabling government to implement innovations
at scale;
 Promoting community acceptance and uptake of innovations.
Based on these activities we developed a topic guide that was
piloted in Addis Ababa by researchers from Ethiopia, India, Nigeria
and the UK, and minor adaptations were made to reﬂect country
contexts. Between July 2012 and April 2013 we conducted ﬁfty
semi-structured interviews in each of the three settings with pur-
posively selected stakeholders representing government, devel-
opment partner agencies, civil society organisations including
externally funded MNH implementers, professional associations
and academic institutions. All interviewees had a role in the ﬁeld of
MNH or in-depth knowledge of issues surrounding the scaling-up
of MNH innovations. Interviewees included: directors and man-
agers, programme ofﬁcers and coordinators, technical advisors, and
research and evaluation ofﬁcers.
Our interviews focussed on ways externally funded implemen-
ters e civil society and academic organisations funded by bilateral
and philanthropic donors including the Bill & Melinda Gates
Foundation e develop, deliver, evaluate and position for scale-up
relatively small scale MNH-related ‘innovations’, which we deﬁne
as approaches that are new in a particular programme context with
the aim of improving MNH. Some of these innovations promote
community behaviour change such as demand for new products,
services or approaches, while others aim to enhance coverage,
quality, efﬁciency and equitable delivery of existing government
MNH services in rural settings. Illustrative examples are given in
Box 1.
The interviews were conducted by NS, RD, DB, AW and FF and
other researchers trained in qualitative methods using the topic
guides. Respondents gave informed consent before interviews
which took place in private spaces to maintain conﬁdentiality.
Sound recordings were used to capture interview data. Expanded
ﬁeld notes (Halcombe and Davidson, 2006) were written soon after
each interview consisting of detailed notes organised under ana-
lytic themes including quotes to illustrate interviewees' voices.
Data capture and analysis occurred concurrently, with interviewers
noting interpretations and emerging hypotheses for further
exploration in subsequent interviews.
The analysis involvedmultiple stages: 1) NS, DW, FW, RD and DB
attended an analysis workshop in London in December 2012 where
emerging ﬁndings were reviewed and jointly agreed, and a
Table 1
Attributes of scalable health innovations.
Relevant & important
B Addresses important and/or visible health
problems/needs
Effective & advantageous
B Impacts positively on communities' health
B Has a comparative advantage over other
innovations
Observable beneﬁts
B Beneﬁts and health impacts are visible
B Beneﬁts are easily demonstrated through
evidence
Acceptable to health
workers & communities B Culturally acceptable to sociocultural norms,
religions, language, health beliefs and practices
B Appropriately branded using ideas and lan-
guage meaningful to users
B Seen as being owned by communities
B Works with existing community structures and
actors including village committees and tradi-
tional birth attendants
B Beneﬁts and incentivises health workers
B Does not burden health workers by adding to
their workload or making them more
accountable for failure
Simple & low cost
B Simple/convenient to use and easily under-
stood by health workers and communities
B Low cost to implement at scale and/or cost
effective
B Low human resource inputs required
B Places no/minimal cost burden on user
communities
Aligned & harmonised
B Builds on and aligns with existing government
health systems
B Addresses needs/ﬁlls gaps in government
health programmes
B Coordinates with other donor programmes
Adaptable
B Adaptable to different geographical, socioeco-
nomic and cultural contexts
B Adaptable to different health systems contexts
Sustainable
B Avoids/has low recurrent costs
B Includes local income generating schemes
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comparison; 2) NS and DW systematically analysed the expanded
ﬁeld notes using Nvivo Version 10, adopting a framework approach
(see Pope and Mays, 2000) whereby a priori and emerging themes
were coded; 3) themes were then tabulated using the common
analytic framework; 4) the paper was drafted by NS and reviewed
by all authors to conﬁrm the ﬁndings are accurately and coherently
presented; 5) ﬁndings were presented to interviewees and other
country stakeholders in India, Nigeria and Ethiopia and research
brieﬁngs were produced summarising study messages.
Interviewers were professionally trained qualitative researchers
who understood the importance of capturing interviewees' per-
spectives rather than their own. Interviewees were all pro-
fessionals, with many in senior positions, although the power
differentials between them and the interviewers were limited. Our
investigator triangulation approach whereby interpretations were
compared and agreed among the researchers (Seale, 2004)
enhanced our conﬁdence in the results reported: multiple re-
searchers contributed to each set of expanded ﬁeld notes, and our
analysis workshop meant interpretations and cross-country com-
parisons were jointly agreed. While externally funded implemen-
ters often reﬂected positively on their work the fact that we sought
perspectives of individuals from different organisations and our
relatively large qualitative sample meant we are conﬁdent we are
presenting a balanced account. Our selected interviewees represent
a range of relevant organisations which enabled us to compare
viewpoints and triangulate the data by cross-checking in-
terviewees' accounts. Indeed, we found considerable consistency
between interviewees' views. In this paper we draw out the most
important themes commonly agreed among the different constit-
uencies of interviewees, and point to major differences between
countries.
Ethical approval for IDEAS was granted by: the London School of
Hygiene and Tropical Medicine Ethics Committee; the Ethiopian
Federal Ministry of Science and Technology together with IRB
approval for Amhara, Oromia, SNNP and Tigray regions; SPECT-ERB
in India; the Nigerian National Health Research Ethics Committee
and Gombe State of Nigeria Ministry of Health Headquarters.
3. Results
Based on the themes emerging from our 150 interviews we
identiﬁed key activities externally funded implementers adopted to
catalyse scale-up as follows:
 designing scalable innovations;
 planning for scale-up by:
B embedding scale-up in programme design;
B building implementer capacity to catalyse scale-up;
 persuading government to accept, adopt and ﬁnance in-
novations at scale through:
B adopting effective approaches to advocacy;
B presenting evidence;
B involving government;
B invoking policy champions and networks;
B harmonisation;
B policy alignment; supporting and enabling government to scale-up; and
 promoting community acceptance and uptake of MNH
innovations.
The following sections explore each of these activities in turn.
3.1. Designing scalable innovations
Respondents identiﬁed multiple attributes of innovations that
increased the prospects of government adoption and community
uptake at scale (Table 1). They stressed how central it was to get an
innovation right, making it critical to allocate enough time to
Table 2
Implementer capacity for catalysing scale-up.
 Staff capacity. Staff with expertise and dedicated time for evaluation, advo-
cacy and communication.
 Technical capacity. A strong track record for effective delivery and producing
trustworthy evidence.
 Reputation. A reputation for integrity and sincerity rather than being
ﬁnancially orientated.
 Leadership. Charismatic leaders able to convince decision makers.
 Networks. Strong relationships with the government and other actors.
 Grant size and length. Implementers with larger, longer grants have more
inﬂuence.
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the most scalable elements of an innovation. However it is difﬁcult
to design innovations with all of these attributes e compromises
are inevitable: ‘When you say something was successful, it does not
imply that it was perfect’ reﬂected a civil society interviewee in Uttar
Pradesh. Interviewees described challenges in addressing socio-
cultural norms such as hegemonic gender relations and the Indian
caste system, often making it easier to stimulate community
acceptance of technologies than behaviour change. Others
described a tension between developing high quality innovationse
‘boutique projects’ requiring considerable effort, time and ﬁnancial
resourcese and simple, low cost innovations attractive to resource-
conscious government decision makers. A civil society interviewee
in India said: ‘In order to look good we invest so many resources… but
after the project ends it's the end of everything. You cannot have a
programme that's so resource intensive!’.
3.2. Planning for catalysing scale-up
3.2.1. Embedding scale-up in programme design: ‘… do your
homework ﬁrst before implementing a programme’
Respondents acknowledged the importance of embedding cat-
alysing scale-up within programme design, although they accepted
that this is often more of an afterthought than well-integrated
within programmes; indeed thinking on scale-up evolves over a
programme's life. Interviewees talked of the importance of having
an advocacy plan detailingmethods and timing of advocacy, who in
government to advocate to and plans for communicating evidence.
Donors and implementers therefore need to allocate ﬁnancial,
human and technical resources to catalysing scale-up, without
which implementers inevitably concentrate on core programmatic
deliverables. Interviewees argued that donors should ﬁnancially
incentivise implementers. An Indian academic explained: ‘… do-
nors should set aside funding and tell the grantees that 30% you will
invest in … scaling-up … But you have to let them know because
without that they will look for their next grant’. Others stressed the
importance of allocating sufﬁcient time e ‘For scale-up it takes time
e two, three years minimum’ according to an Ethiopian develop-
ment partner e but accepted this is often overlooked or under-
estimated, as short-term grants to achieve ambitious programmatic
deliverables are the norm. An academic in India described this
commonly experienced frustration: ‘So many times the idea is just at
its tipping point of becoming scaled-up when the donors pull out’.
According to our interviewees assessing the political climate,
policy priorities, government systems, institutions and procedures
is an important early activity for implementers. This helps to inform
plans for catalysing scale-up, maximise alignment between in-
novations and country priorities and systems and anticipate insti-
tutional blockages within government systems. A researcher in
Nigeria said: ‘Politics, perceptions and power … we don't want to
knowingly run afoul of these things!’. Stakeholder analyses can help
identify allies (and potential rivals) e inﬂuencers of government
policy such as UN agencies in Ethiopia, and traditional rulers of
northeast Nigeria e and key government ofﬁcials to engage. Ac-
cording to a Nigerian civil society interviewee: ‘… as an external
person [you need] to do a little stakeholder mappinge knowwho your
allies are e preach to them, empower them, make them understand,
see the evidence, share your vision…’.
Finally, respondents pointed to the value of understanding the
attitudes, priorities and motivations of health workers and com-
munities to inform the development of scalable innovations, as a
Nigerian government interviewee acknowledged: ‘…most pro-
grammes are imposed on people without asking or knowing what they
really want… No matter how well-thought out such programmes are,
they will fail’.3.2.2. Building implementer capacity to catalyse scale-up: ‘having
technical strength and knowledge’
Our respondents agreed that not all programme implementers
have the same capacity to catalyse scale-up regardless of the scal-
ability of the innovations they developed, and that donors should
take steps to build implementers' capacity for catalysing scale-up.
Respondents listed several capacities as important in enabling
implementer efforts to catalyse scale-up (Table 2).
3.3. Persuading government to accept, adopt and ﬁnance MNH
innovations at scale
Interviewees in the three settings stressed that federal or state
governments are themain potential ‘owners’ of innovations at scale
as they have the legitimacy and resources to do so. Bilateral donors
on the other hand do not have sufﬁcient ﬁnances individually to
scale-up innovations. While the Indian private health sector is
huge, and is recognised as having substantial potential in scaling
innovations, at the time of the interviews efforts to invoke this
sector were in their infancy. A development partner speaking about
India said: ‘Ultimately the owner of scale-up is going to be the gov-
ernment e the receiving environment. The buy-in and ownership
within that institution is important’. Hence, interviewees emphas-
ised the importance of persuading and enabling government to
scale innovations through effective advocacy and communication
of evidence, involving government, invoking policy champions and
networks, and harmonisation and alignment. The following sec-
tions explore each of these activities in turn.
3.3.1. Adopting effective approaches to advocacy: ‘it's a lot of
discussion isn't it?’
Interviewees identiﬁed multiple advocacy methods they had
used to persuade government to adopt and ﬁnance MNH in-
novations at scale including: panel discussions with ofﬁcials; pre-
senting at public meetings or conferences; promoting their work at
development partners' fora; inviting government to project review
meetings; presenting evidence in reports and journals; producing
brochures and newsletters; and project websites and social media.
Some interviewees acknowledged that exploiting personal con-
nections to lobby government could also be important, as an Indian
academic conﬁded: ‘This is India ework happens over tea, coffee and
dinners…’.
A widely accepted reality was that substantial time, effort and
determination are needed: an important principle is ‘continual
advocacy’e early and ongoing advocacy, and repeating advocacy as
government administrations and ofﬁcials change over time. An
implementer in Ethiopia said: ‘… use some sort of dialogue … to
inﬂuence decisions more than anything else…’, while a development
partner speaking about Nigeria said: ‘I think it's a lot of discussion
isn't it? It requires spending a lot of time with the relevant people,
sitting down and exposure and discussion …’. Advocacy is usually
required at multiple levels of government. In Nigeria interviewees
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reﬂecting state autonomy to set priorities and budgets. This was
also true in India where states translate the federal government's
National Rural Health Mission (NRHM) into state Programme
Implementation Plans. Interviewees in Ethiopia explained that if an
innovation is a new technology, vaccine or medication and/or re-
quires changes in national legislation they ﬁrst approach federal
government, whereas expanding programmes accepted by federal
government required targeting relevant Regional Health Bureaus.
The extent to which implementers can challenge government
varies between the three countries. Interviewees felt the Uttar
Pradesh and northeast Nigerian state governments increasingly
respond to civil society in shaping policy decisions e ‘naming and
shaming’ as a Nigerian development partner remarked. Civil society
pressure was reported as having inﬂuenced recent increases in
Nigerian Government resources for MNH and other health pro-
grammes. The Ethiopian Government on the other hand maintains
tighter control over policy decisions: ‘Maintaining a good relation-
ship with the government is primarily important’, according to a civil
society interviewee. Indeed, as discussed below, in all three settings
involving government in different stages of an externally funded
programme was seen as crucial rather than acting as a critical
advocate.3.3.2. Evidence for catalysing scale-up: ‘well presented information
makes a humungous impact’
The success of advocacy is enhanced if it is supported by evi-
dence: interviewees agreed that while evidence cannot guarantee
scale-up, lack of strong evidence makes it unlikely government will
adopt an innovation. Key considerations are: types of evidence;
strength of evidence; communication of evidence; and a govern-
ment's use of evidence in decision making.
It is commonly expected that externally funded implementers
conduct quantitative surveys to test innovation outcomes and im-
pacts. Our interviewees stressed, however, that presenting addi-
tional types of quantitative and qualitative evidence strengthens
implementers' case for scale-up and gives government a stronger
basis for making informed decisions about what to scale and how
(see Table 3 for examples).
The willingness of decision makers to consider evidence de-
pends on perceptions of its quality. A government interviewee in
Nigeria explained: ‘If evidence is derived through due process and is
reliable it inﬂuences policy positively’. It is important that imple-
menters show their evidence is based on a robust methodology and
rigorous data collection and analysis: ‘Evaluation is so critical that
it's immoral to think of scaling-up without a robust evaluation exer-
cise’, according to a researcher in India. Nevertheless, producingTable 3
Types of evidence for catalysing scale-up.
 Quantitative evidence demonstrating outcomes and impacts. According to
a Nigerian academic: ‘You must be able to show that the package you are trying
to sell has actually worked… improvement in the lives of women and children…’
 Evidence on costs of implementing innovations/cost effectiveness/esti-
mated costs of scale-up. A civil society interviewee in India explained that
this is critical: ‘When it's required to take it to scale, government ﬁrst asks what is
the cost?’
 Qualitative process data and operational lessons. As an Ethiopian devel-
opment partner said: ‘What is needed is more evidence on how to implement
programmes e operational level evidence’
 Mapping and needs/gaps assessments. An implementer in Ethiopia
explained: ‘…we have to show the magnitude and seriousness of the problem…’
 First hand evidence. Site visits and documentary ﬁlms to engender emotional
buy-in and help decision makers appreciate realities on the ground.
 Benchmarking international best practices from programmes in other
countriesstrong evidence can be a challenge: implementers acknowledged
the difﬁculties attributing outcomes to speciﬁc components of
complex, multi-layered programmes in large, changing geograph-
ical settings. Further, despite qualitative evidence being recognised
as a useful complement to quantitative, invariably the latter is
privileged by government ofﬁcials as more valid than the former:
‘… know your audience … if I am presenting to commissioners for
health I better have my statistics, my pie charts, my bar diagrams…’
according to a Nigerian researcher.
Interviewees emphasised that evidence should be seen as un-
biased by interests, but acknowledged that implementers were
under pressure to showcase success, as a development partner
speaking about India explained: ‘Evidence should be unbiased e
implementers doing self evaluation and giving a positive picture get
taken with a pinch of salt …’. Implementers' reputations for tech-
nical competence and integrity reinforces the trustworthiness of
their evidence: ‘They are highly credited for their baseline study …
and highly accepted and referred by both the government and
implementing partners …’ an interviewee from an Ethiopian civil
society organisation shared. Several implementers worked with
academic institutions or consultants to strengthen their monitoring
and evaluation capacity or commissioned external evaluators since
this carries more weight than internal evaluation.
Our respondents identiﬁed important principles for communi-
cating evidence. Presenting simple, short, powerful messages using
methods and language appropriate to the audience was deemed
essential: ‘… well written, well presented information makes a
humungous impact on decision making!’ an Indian expert explained.
While interviewees stressed the importance of disseminating evi-
dence widely at different levels of government a targeted approach
can be critical e presenting evidence to ofﬁcials with authority to
act. An implementer in India felt that failing to do this was prob-
lematic: ‘The dissemination meeting wasn't well attended by people
whowould be able to take this forward… not by very high level people
…’. Other interviewees argued that communicating evidence to
civil society organisations could empower them to make demands
on government to adopt and ﬁnance innovations. This appears to be
an increasingly realistic prospect in Nigeria and India, although less
so in Ethiopia where civil society is weaker. A civil society inter-
viewee in Nigeria commented: ‘The democratic space is now open for
[civil society] to speak on issues unlike in the past’.
Alignment and harmonisation are important principles to adopt
when using evidence to catalyse scale-up. Alignment involves
ensuring evidence ﬁts closely with government indicators since
this signals how an innovation helps achieve targets, as a devel-
opment partner in Nigeria explained: ‘… the ministry wants to see
the results e how the innovation can contribute to the ministry and
the health sector…’. It is also critical to synchronise communication
with annual policy and budget decision making cycles, and to
respond to changes in government priorities. Harmonisation e
meaning coordination among external donors and implementers e
is also important but not always practiced as an Ethiopian expert
explained: ‘… everyone says mine is the best!… organisations boldly
try to make their innovations accepted…’.
Despite the belief that evidence is critical, our interviewees
acknowledged the political nature of decision making such as
politicians' largesse to those who elected them or supporting pol-
icies that attract more votes. A Nigerian government interviewee
said that: ‘… when an individual is appointed into political positions
or elected into political ofﬁces… he wants to please his ring of friends
and associatese that makes decision making not quite representative’,
and an Indian civil society interviewee explained: ‘… policies are not
alwaysmade based on evidence… sometimes huge decisions aremade
within an hour …’. Sensitivities about evidence that contradicts
government are also an issue. ‘That's a real problem e they withhold
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Indian civil society interviewee said: ‘If the data doesn't favour them
they become defensive’. Unsurprisingly views varied about the
extent to which evidence informs government decision making e
and interviewees pointed to variations across the states/regions of
Nigeria, India and Ethiopia and between government administra-
tions and individuals. Short falls in the use of evidence were
explained by political interests, limited government capacity to use
evidence, problems of low quality, poorly communicated evidence
and weak alignment and harmonisation of evidence.
3.3.3. Involving government: ‘they must be part of it’
Interviewees stressed the importance of early and ongoing
government involvement in planning and designing programmes
andmonitoring and evaluation activities through regular meetings,
site visits and sharing strategies and plans. An Indian implementer
said: ‘Starting from the planning phase itself regular updating is the
key. Take their inputs and slowly they get convinced when they see
progress…’. Our interviewees said that creating good relationships
with individual ofﬁcials is vital since trust and conﬁdence in
externally funded programme enhances the likelihood of govern-
ment ownership. Working with government also helps align in-
novations with government policies, programmes and systems. A
civil society interviewee in Ethiopia clariﬁed why this is important:
‘… involving decision makers in every step … dialogue with them so
that they believe in it thereby creating ownership … creating trust by
ﬁlling gaps, producing results and supporting their initiatives…’.
However there can be difﬁculties in involving government.
Pressures to rapidly implement a project means that there is a
temptation to cut corners, although as a researcher in India
explained this may not pay dividends: ‘…what they actually mean is
they hold meetings in the capital city, in the hotels … the tokenistic
approach to [government] involvement … doesn't work’. Moreover,
changes in government administrations and reshufﬂing and attri-
tion of ministers and bureaucrats means that new relationships
need to be sought over the course of a programme, as another In-
dian researcher explained: ‘… how many mission directors changed
in Uttar Pradesh, how many district directors changed in UP? What
does government buy-in imply?’.
3.3.4. Policy champions and networks: ‘those who have the ear of
decision makers …’
Interviewees agreed that invoking policy champions can
strengthen advocacy for innovation scale-up and raise the proﬁle of
MNH issues. Champions include senior ofﬁcials within federal, state
or local government, legislators, ‘ﬁrst ladies’ and ‘boundary span-
ners’ (individuals linking government, civil society and other or-
ganisations). One implementer explained their organisation's work
beneﬁted from the patronage of the Ethiopian President and sup-
port of the Prime Minister, while an expert explained: ‘… policy
change requires champions from government … usually change hap-
pens when it comes from within the system rather than outside…’. A
Nigerian civil society organisation interviewee underlined the
beneﬁts of powerful government champions: ‘… you ﬁnd you hardly
need push… they will be the ones who will drive the process for you
…’.
Networking and alliance building with UN agencies and donors,
inﬂuential civil society organisations, professional associations,
academic institutions, sensitised mass media and celebrities can
leverage support for an innovation or raise political attention. A
development partner in Ethiopia explained that this was valuable if
the implementer has limited capacity for advocacy: ‘I don't think
[the grantee is] capable of inﬂuencing policy. So there's the question of
whether they can feed into other [actors] who can’. Community
leaders can act as powerful allies, especially in northeast Nigeria. Avisit by Bill Gates solidiﬁed state governors' commitments and
fostered traditional rulers' support, which was signiﬁcant since
their endorsement of a health programme affects state government
decisions and community acceptance. An implementer explained
that the charismatic Emir of Kaltungo, a local leader, has substantial
interest in and inﬂuence over health issues in the region: ‘If he
didn't buy into it they wouldn't be doing all those things’.
3.3.5. Harmonisation: ‘the issue of competition is crazy!’
Poor harmonisation among development agencies and imple-
menters fuelled by competing interests and priorities, competition
for donor funding and pressure to attribute outcomes to pro-
grammatic efforts was described by our interviewees as an
important challenge to scale-up: ‘the more fragmented we are the
less successful we will be’ a development partner in India
acknowledged. Robust efforts at donor coordination in Ethiopia,
and increasingly in Uttar Pradesh, are not matched by those in
Nigeria where a civil society interviewee described federal and
state ministries' leadership over development agencies as limited:
‘… the federal government should be in the driving seat to coordinate
all development work, but … cannot say ‘no’ to funding…’.
Interviewees agreed that better harmonisation through
engagement in government-led partner coordination mechanisms,
including federal and regional level Technical Working Groups in
Ethiopia, the Partners' Forum in Uttar Pradesh and the Nigerian
Core Technical Committee of the National Partnership for Maternal,
Newborn and Child Health, underpinned efforts at catalysing scale-
up. Engaging in such mechanisms can help government to strate-
gically coordinate and deploy innovations funded by different do-
nors at scale. A government interviewee explained that
government leadership is strong in Ethiopia: ‘All plans are discussed
with partners andwe put together an action plan’, and a development
partner agreed: ‘The government is very good a balkanising use there
is very little overlap …’.
Embracing partnership mechanisms may also encourage
development partners to collectively put forward the best in-
novations rather than, as is commonly the case, competing for
government attention: ‘… it's our moral and ethical duty to work
together … we have to go beyond our little thing and make sure that
we’re asking for common asks …’ argued an Indian civil society
interviewee. Such structures may serve as a conduit for imple-
menters' technical inputs in support of government scale-up efforts
as an Ethiopian implementer explained: ‘We are at the table when it
comes to maternal and newborn child health activities’. They also
have the potential to promote lesson sharing among external
partners, meaning new innovations can build on learning from
other programmes. An Indian civil society interviewee argued for
greater harmonisation among externally funded programmes:
‘People in India are not combining their expertise… instead of wasting
time reinventing the wheel we need to come together …’.
Interviewees pointed out that partnerships and joint working
arrangements with other implementers, development partners,
universities and professional associations is advantageous to scale-
up: partners could be called on for technical inputs, capacity
building, training and other resources. An Ethiopian civil society
interviewee said: ‘Generally the source of inﬂuence and power of an
actor is partnership!’
3.3.6. Policy alignment: ‘so long as it contributes to their vote bank
they will be receptive …’
Aligning innovations with government priorities, policy frame-
works and targets such as India's NRHM and corresponding state
Programme Implementation Plans, the Health Extension Pro-
gramme and Health Sector Development Programme IV in Ethiopia
and the National Strategic Health Development Plan in Nigeria is
Box 2
Key activities to catalyse scale-up.
 Designing innovations for scale
 Integrating scale-up within programme plans
 Building organisational capacity
 Advocating effectively with government decision makers
 Generating and communicating strong evidence
 Ensuring government involvement throughout a project
 Invoking policy champions and networks of allies
 Aligning with government systems, policies, priorities
and targets
 Harmonising efforts with other development partners and
implementers
 Supporting and building the capacity of government for
scale-up
 Working with community leaders, media and others to
stimulate diffusion of innovations among communities
N. Spicer et al. / Social Science & Medicine 121 (2014) 30e3836seen by interviewees as critical to government adopting an inno-
vation. A development partner in Ethiopia explained: ‘… if it's in
line with their vision and structure and helping to achieve what they
want to achieve it will be most likely accepted…’. Moreover, framing
of innovations as serving political ideas and interests can attract
government attention, because, as a Nigerian civil society inter-
viewee explained: ‘Every government wants to come back for a sec-
ond term and it's good if you canmake them believe that if they deliver
on this they have the chance of being popular and re-elected …’.
Nevertheless policy alignment was not without its difﬁculties:
changes in government administrations and in policy strategies
mean externally funded programmes can struggle to remain rele-
vant. An Ethiopia civil society interviewee said: ‘… by the time you
are to scale it up the programme may not be a priority for the gov-
ernment …’.
Many externally funded innovations included in the study work
within and aim to strengthen existing health systems, which in-
terviewees described as enhancing government commitment to
scale-up: ‘… it's not creating parallel systems but rather helping the
system to do it more innovatively and efﬁciently so that it can function
even after we withdraw,’ said a civil society interviewee in Nigeria.
Nevertheless old debates persist about working within or outside
government systems, with interviewees sharing their frustrations
about delays and lack of progress while working within health sys-
tems fraught with bureaucracy and corruption, weak human re-
sources, poor infrastructure, and dysfunctional information and
logistics systems, making it tempting to work outside government
systems in order to show results within relatively short grant periods.
Speaking about India a development partner said: ‘…we try to scale-
up things throughabroken system. It's difﬁcult to succeed in that context’.
3.4. Supporting government to implement MNH innovations at
scale
The above sections explored ways externally funded implemen-
ters have sought topersuadegovernment to accept, adopt andﬁnance
the scale-up of MNH innovations. There are also ways they have
supported government to implement innovations at scale. Several
implementers in the three countries act as technical partners to
support government to formulate and implement policies and pro-
grammes at scale, and their evidence is valuable for informing gov-
ernment about how to do so. Inputs include drafting and developing
policy strategies, guidelines, tools, protocols, manuals and training
curricula jointly with government. A development partner speaking
about Ethiopia explained: ‘I don't know that the grantees have played
much of a role in kick starting or leading scale-up but they've certainly
been quick at the table and part of discussions in shaping what looks
right’. Interviewees described implementer efforts to strengthen the
capacity of government staff involved in scaling innovations and
health systems more broadly including decision making processes,
policy and regulatory environments, management and human
resource systems, ﬁnancial management and using evidence. A
researcher in Nigeria explained that an important way to catalyse
scale-up is to strengthen government: ‘You have to at least do some
capacity building with those you want to work with…’.
Supporting government to scale-up innovations was something
interviewees described as particularly important in Ethiopia where
nongovernmental partners are expected to position themselves as
‘trusted partners’ within government set parameters. As a devel-
opment partner explained the role of externally funded imple-
menters is to be responsive: ‘… it's best to start with programmes
identiﬁed by government… nowadays it's not acceptable… to start a
small programme, pilot it, see its outcome and scale it up…’. Indeed it
is common for government to invite development partners and
implementers to contribute ﬁnancial and technical resources toscaling health programmes. Another development partner shared
how an Ethiopian Ministry of Health-led programme scaled up an
externally ﬁnanced MNH innovation:
… a good example is neonatal sepsis management. Good evidence
was coming from SNNP region: it is doable and was initially
implemented by Save the Children. The Ministry with UNICEF came
up with new policy and guidelines on neonatal sepsis management
to be implemented all over the country … the Ministry of Health
said this is what we want to do and invited other partners to
support the programme…
3.5. Promoting community acceptance and uptake of MNH
innovations
The diffusion of innovations between communities without
government intervention e the ‘ripple effect’ e was described by
interviewees as one way to catalyse scale-up beyond implementer
programme areas. This may involve working with community
‘opinion leaders’e individuals and organisations able to precipitate
the diffusion of ideas e including community groups, women's
groups, traditional and religious leaders, churches and mosques. In
northeast Nigeria the endorsement of traditional authority is an
essential prerequisite for community acceptance of a programme:
‘Working with traditional rulers and religious groups is very impor-
tant: these are the groups that make it work at community level…’.
Stimulating the diffusion of innovations through mass and local
media and by word of mouth has also been effective in some cases.
Some grants established communitymobilisation teams to improve
relationships between communities and health professionals, or
trained role models to spread ideas, an approach described by a
Nigerian civil society interviewee: ‘Teach the communities the basics,
how to carry the message and spread the knowledge … using the
strategy of “each one teaching one”’. According to our interviewees
the way an innovation is introduced inﬂuences its uptake: unlike
top-down programmes, community participation helps sustain and
spread innovations after a project is complete.
4. Discussion
Our study supports and adds depth to the literature on scale-up
and diffusion of innovations. Existing literature highlights the
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context, building support and increasing capacity of user organi-
sations, partnership working and promoting spontaneous scale-up
among users and communities (Cooley and Kohl, 2006; Simmons
et al., 2007; WHO and ExpandNet, 2009, 2010, 2011; Bradley
et al., 2012). Our data suggest that these, and indeed other steps,
can be taken by implementers to catalyse scale-up (Box 2). We
found that time, money, coordination and context are critical, cross
cutting issues. Externally funded implementers need time, energy
and determination to undertake the multiple activities required to
catalyse scale-up. Hence, implementers and donors should ensure
efforts to catalyse scale-up are written into programme timelines,
and that staff time is dedicated for scale-up related work. Yet im-
plementers face time constraints and challenges. Longer grants are
better geared for scale-up since there is more time for programmes
to mature and for implementers to advocate and support govern-
ment. However donors and implementers are usually constrained
by short two to three year grants that are expected to show rapid
results and many of our interviewees called for longer, more pre-
dictable funding, without which impacts are likely to be small-scale
and temporary at best.
Money is critical to scale-up. Government funding for MNH is
reported as growing in the three countries e in no small part
fostered by Millennium Development Goals (MDGs) Four and Five
(reducing child and maternal mortality). However in Nigeria, pri-
mary healthcare is a low government priority and is constructed as
a donor responsibility making government reluctant to commit
ﬁnances to scale-up. Moreover, government's ﬁnancial pledges are
not always kept and implementation is hampered by the security
crisis in the northeast states. The situation is more positive in India
and Ethiopia. Substantial new funding is available in Uttar Pradesh
through the NRHM programme, while the Ethiopian Government's
Health Extension Programme provides fertile ground for scaling
select innovations with donor funding. But there are challenges and
tensions relating to money. In all three settings limited ﬁnances
inevitably constrain government's ability to scale innovations, and
implementers often compete for attention: low-cost innovations
have more chance of government acceptability, especially if evi-
dence of their costs can be presented. Implementers are torn be-
tween concentrating ﬁnancial and other resources on ‘boutique
projects’ to impress their donors, and developing simple, low cost
innovationsewhich are likely to involve compromises over quality
and scope. Pressure to achieve core programme deliverables means
that if catalysing scale-up is not an explicit deliverable, imple-
menters are unlikely to put energy into it. Indeed, it may be in their
interests not to jeopardise future funding by handing over in-
novations to government.
Partner coordination mechanisms are emerging as spaces to
strengthen government oversight and coordination of externally
funded programmes, foster improved harmonisation and promote
evidence sharing. These are important underpinnings of efforts to
catalyse scale-up e especially in terms of externally funded pro-
grammes sharing learning about effective innovation designs that
make better use of limited time and money available. While there
are signs the coordination mechanisms in the three settings are
leading to improvements, they are relatively new and untested, and
our respondents criticised them for struggling to improve infor-
mation sharing very signiﬁcantly. Aligning innovations with gov-
ernment priorities, targets and systems is critical to scale-up. Yet
implementers and donors are acutely aware of the compromises
this may involve. The beneﬁts of involving government are offset by
potential delay, and working within ‘broken’ government systems
means implementers may struggle to show tangible results in short
timeframes. Implementers therefore need to assess and respond to
the realities of political decision making when they plan forcatalysing scale-up. In the words of an interviewee in India:
‘Scaling-up is a craft rather than a science e political rather than
technical’.
Contexts within which innovations are introduced are impor-
tant (Cooley and Kohl, 2006; WHO and ExpandNet, 2009, 2010,
2011; Simmons et al., 2010; Linn et al., 2010). A beneﬁt of our
study is that it compares three country contexts and reveals a
number of contextual differences that have implications for scale-
up. In northeast Nigeria, where security remains a critical prob-
lem, health is considered the domain of development partners, and
state governments are open to donor programmes provided they
are supported by funding. In Ethiopia while the government is
highly dependent on external funding it strongly coordinates
external partners who need to closely involve government in all
stages of a programme. Uttar Pradesh on the other hand has sub-
stantial funding for rural healthcare through the NRHM e external
partners' roles tend to be limited to technical support, although the
state government is reported as open to new ideas and partnership
working.
Our study has a number of limitations. We simplify complexity
and provide only a snapshot in time in rapidly changing settings.
The study elicited certain decision makers' perspectives but not
those of implementers or beneﬁciaries or other decision makers
who may have offered contrasting perspectives. We were unable to
measure or rank the importance of the different activities to ca-
talyse scale-up. A follow-up study in 2014 will explore a number of
case study innovations in depth and assess the relative importance
of different activities to catalyse scale-up.5. Conclusion
There is no magic bullet solution e implementers need to
embrace most if not all of the activities summarised in Box 2 to
catalyse innovation scale-up. What is clear is that catalysing scale-
up requires substantial effort and commitment not just from im-
plementers but from donors that need to ﬁnance and support
implementer capacity to catalyse scale-up, insist implementers
embed scale-up plans within programmes and ﬁnancially enable
and incentivise implementers through longer grants. Government
commitment is also vital: governments need to work closely with
externally funded implementers to maximise relevance, value and
scalability of innovations, and strengthen coordination mecha-
nisms to elicit partners' inputs and technical support, and for
exchanging and capturing valuable learning.
Global declarations and initiatives such as the Paris Declaration
of Aid Effectiveness and the International Health Partnership signal
global resolve to improve aid effectiveness. The Nigerian and
Ethiopian Governments are International Health Partnership sig-
natories, as are most development partners supporting MNH pro-
grammes in those countries. Adhering to the principles of aid
effectiveness e more predictable, longer term aid commitments,
improving harmonisation and alignment and better government
ownership of externally funded programmes e is likely to
strengthen efforts of implementers, donors and governments to
catalyse scale-up.Acknowledgements
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